President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

Protesters at the Kentucky Capitol — brought together by the internet — shared their anger at recent moves by President ...

Trump issued a fabulous new executive order on Jan. 28 entitled “Protecting Children from Chemical and Surgical Mutilation.” What, you might ask, is meant by ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

are automatically captured in an electronic medication administration record. The hospitals in the network using BPOC apply bar codes to all inpatient medications. Bar codes can be damaged or lost ...

The drug is for moderate to severe acute pain. The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...